Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
Y
2926
DELISTED
Alleghany Corp
Y
| $606K | ﹤0.01% |
987
-37,363
| -97% | -$22.5M |
|
2927
Oil-Dri
ODC
$1.32B
| $603K | ﹤0.01% |
30,006
+5,350
| +22% | +$103K |
|
|
AMRN
2928
CALL
Amarin Corp
AMRN
$296M
| $602K | ﹤0.01% |
+10,000
| New | +$742K |
|
2929
Preformed Line Products
PLPC
$2B
| $601K | ﹤0.01% |
9,230
-22,002
| -70% | -$1.55M |
|
2930
Strategic Education
STRA
$1.88B
| $601K | ﹤0.01% |
5,949
-6,540
| -52% | -$619K |
|
2931
LeMaitre Vascular
LMAT
$1.82B
| $600K | ﹤0.01% |
+16,571
| New | +$574K |
|
2932
Invesco Dorsey Wright Energy Momentum ETF
PXI
$53.7M
| $599K | ﹤0.01% |
15,773
-5,674
| -26% | -$220K |
|
|
CFMS
2933
DELISTED
Conformis, Inc. Common Stock
CFMS
| $598K | ﹤0.01% |
16,493
-8,363
| -34% | -$351K |
|
2934
Pacific Biosciences
PACB
$466M
| $594K | ﹤0.01% |
289,523
+163,767
| +130% | +$425K |
|
2935
Vanguard Consumer Discretionary ETF
VCR
$6.08B
| $592K | ﹤0.01% |
3,733
+2,259
| +153% | +$369K |
|
2936
Cinemark Holdings
CNK
$4.37B
| $588K | ﹤0.01% |
15,614
-8,886
| -36% | -$337K |
|
2937
Guggenheim Strategic Opportunities Fund
GOF
$2.16B
| $588K | ﹤0.01% |
28,961
+8,257
| +40% | +$170K |
|
|
CHSP
2938
DELISTED
Chesapeake Lodging Trust
CHSP
| $584K | ﹤0.01% |
20,985
-72,592
| -78% | -$1.95M |
|
2939
CALL
Celldex Therapeutics
CLDX
$3.25B
| $583K | ﹤0.01% |
+16,667
| New | +$646K |
|
|
KBAL
2940
DELISTED
Kimball International
KBAL
| $583K | ﹤0.01% |
34,195
-23,221
| -40% | -$411K |
|
2941
Federal Agricultural Mortgage
AGM
$2.37B
| $582K | ﹤0.01% |
6,686
-2,296
| -26% | -$186K |
|
2942
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
| $580K | ﹤0.01% |
+9,442
| New | +$590K |
|
2943
DHI Group
DHX
$188M
| $576K | ﹤0.01% |
359,829
-193,051
| -35% | -$342K |
|
2944
OR Royalties Inc
OR
$7.23B
| $576K | ﹤0.01% |
+59,606
| New | +$629K |
|
2945
Adtran
ADTN
$644M
| $575K | ﹤0.01% |
36,997
-387,556
| -91% | -$6.47M |
|
2946
Nuveen Quality Municipal Income Fund
NAD
$2.73B
| $571K | ﹤0.01% |
43,481
+31,181
| +254% | +$416K |
|
2947
Gladstone Capital
GLAD
$447M
| $568K | ﹤0.01% |
+33,046
| New | +$594K |
|
|
NXTM
2948
DELISTED
NxStage Medical Inc.
NXTM
| $567K | ﹤0.01% |
22,814
-14,155
| -38% | -$344K |
|
|
SRG
2949
Seritage Growth Properties
SRG
$119M
| $564K | ﹤0.01% |
15,864
-300,711
| -95% | -$11.7M |
|
2950
Cornerstone Strategic Value Fund
CLM
$2.09B
| $563K | ﹤0.01% |
+37,458
| New | +$576K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.